Sanofi and partner seek European Medicines Agency review for sleep sickness product

PARIS (Reuters) - French healthcare group Sanofi, along with its business partner, has asked the European Medicines Agency (EMA) to review the fexinidazole product for the treatment of sleeping sickness, the company said on Wednesday.

from Reuters: Health News http://ift.tt/2nrs2Gg
via IFTTT